Norges Bank Takes $45.11 Million Position in Envista Holdings Corporation $NVST

Norges Bank acquired a new stake in shares of Envista Holdings Corporation (NYSE:NVST) during the fourth quarter, Holdings Channel reports. The institutional investor acquired 2,078,001 shares of the company’s stock, valued at approximately $45,113,000.

A number of other large investors have also recently made changes to their positions in the stock. Caitong International Asset Management Co. Ltd boosted its position in Envista by 16,711.1% in the third quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock valued at $31,000 after buying an additional 1,504 shares during the last quarter. Allworth Financial LP boosted its position in Envista by 75.4% in the fourth quarter. Allworth Financial LP now owns 1,805 shares of the company’s stock valued at $39,000 after buying an additional 776 shares during the last quarter. IFP Advisors Inc boosted its position in Envista by 102.9% in the fourth quarter. IFP Advisors Inc now owns 2,112 shares of the company’s stock valued at $46,000 after buying an additional 1,071 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in Envista by 73.1% in the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock valued at $44,000 after buying an additional 949 shares during the last quarter. Finally, EverSource Wealth Advisors LLC boosted its position in Envista by 378.0% in the second quarter. EverSource Wealth Advisors LLC now owns 2,414 shares of the company’s stock valued at $47,000 after buying an additional 1,909 shares during the last quarter.

Analyst Ratings Changes

Several equities research analysts have commented on NVST shares. Morgan Stanley upped their price target on shares of Envista from $19.00 to $21.00 and gave the company an “equal weight” rating in a report on Friday, April 24th. Wall Street Zen lowered shares of Envista from a “strong-buy” rating to a “buy” rating in a report on Saturday, May 9th. Mizuho upped their price target on shares of Envista from $24.00 to $27.00 and gave the company a “neutral” rating in a report on Tuesday, February 10th. Citigroup assumed coverage on shares of Envista in a report on Wednesday, April 15th. They issued a “neutral” rating and a $29.00 price target on the stock. Finally, JPMorgan Chase & Co. upped their price objective on Envista from $26.00 to $29.00 and gave the stock a “neutral” rating in a research report on Thursday, May 7th. Six analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat, Envista currently has a consensus rating of “Hold” and a consensus target price of $28.83.

Envista Trading Up 1.5%

NVST stock opened at $23.45 on Tuesday. The company’s 50-day simple moving average is $25.08 and its 200-day simple moving average is $24.61. The company has a quick ratio of 2.06, a current ratio of 2.44 and a debt-to-equity ratio of 0.47. Envista Holdings Corporation has a 52-week low of $18.25 and a 52-week high of $30.42. The firm has a market cap of $3.82 billion, a P/E ratio of 57.20, a PEG ratio of 1.31 and a beta of 0.88.

Envista (NYSE:NVST) last posted its earnings results on Wednesday, May 6th. The company reported $0.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.31 by $0.05. Envista had a net margin of 2.41% and a return on equity of 7.11%. The business had revenue of $705.50 million for the quarter, compared to analyst estimates of $680.04 million. During the same period in the prior year, the company posted $0.24 EPS. The company’s revenue for the quarter was up 14.4% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. As a group, equities analysts forecast that Envista Holdings Corporation will post 1.42 EPS for the current fiscal year.

Envista Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.